Skip to main content
SpringerLink
Log in

Postmenopausal hormone therapy, SERMs, and coronary heart disease in women

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Grady D., Rubin S.M., Petitti D.B., Fox C.S., Black D., Ettinger B., Ernster V.L., Cummings S.R. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann. Intern. Med. 1992, 117: 1016–1037.

    Article  CAS  PubMed  Google Scholar 

  2. National Center for Health Statistics. Vital Statistics of the United States. US Department of Health and Human Services, Washington, DC, 1987, vol. 2, part A.

    Google Scholar 

  3. Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995, 273: 199–208.

    Article  Google Scholar 

  4. Barrett-Connor E., Grady D. Hormone replacement therapy, heart disease, and other considerations. Annu. Rev. Pub. Health 1998, 19: 55–72.

    Article  CAS  Google Scholar 

  5. Love R., Wiebe D., Feyzi J., Newcomb P., Chappell R. Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment. J. Natl. Cancer Inst. 1994, 86: 1534–1539.

    Article  CAS  PubMed  Google Scholar 

  6. Walsh B., Kuller L., Wild R., Paul S., Farmer M., Lawrence J., Shah A., Anderson P. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA 1998, 279: 1444–1451.

    Article  Google Scholar 

  7. Stampfer M.J., Colditz G.A. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence. Prev. Med. 1991, 20: 47–63.

    Article  CAS  PubMed  Google Scholar 

  8. Bush T.L., Barrett-Connor E., Cowan L.D., Criqui M.H., Wallace R.B., Suchindran C.M., Tyroler H.A., Rifkind B.M. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987, 75: 1102–1109.

    Article  CAS  PubMed  Google Scholar 

  9. Sullivan J.M., Vander Zwaag R., Hughes J.P., Maddock V., Kroetz F.W., Ramanathan K.B., Mirvis D.M. Estrogen replacement and coronary artery disease. Arch. Intern. Med. 1990, 150: 2557–2562.

    Article  CAS  PubMed  Google Scholar 

  10. Henderson B.E., Paganini-Hill A., Ross R.K. Decreased mortality in users of estrogen replacement therapy. Arch. Intern. Med. 1991, 151: 75–78.

    Article  CAS  PubMed  Google Scholar 

  11. O’Brien J.E., Peterson E.D., Keeler G.P., Berdan L.G., Ohman E.M., Faxon D.P., Jacobs A.K., Total E.J., Califf R.M. Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions. J. Am. Coll. Cardiol. 1996, 28: 1111–1118.

    Article  PubMed  Google Scholar 

  12. Newton K.M., LaCroix A.Z., McKnight B., Knopp R.H., Siscovick D.S., Heckbert S.R., Weiss N.S. Estrogen replacement therapy and prognosis after first myocardial infarction. Am. J. Epidemiol. 1997, 145: 269–277.

    Article  CAS  PubMed  Google Scholar 

  13. Sullivan J.M., El-Zeky F., Vander Zwagg R., Ramanathan K.B. Effect on survival of estrogen replacement therapy after coronary artery bypass grafting. Am. J. Cardiol. 1997, 79: 847–850.

    Article  CAS  PubMed  Google Scholar 

  14. O’Keefe J.H., Kim S.C., Hall R.R., Cochran V.C., Lawhorn S.L., McCallister B.D. Estrogen replacement therapy after coronary angioplasty in women. J. Am. Coll. Cardiol. 1997, 29: 1–5.

    Article  PubMed  Google Scholar 

  15. Barrett-Connor E. Postmenopausal estrogen and prevention bias. Ann. Intern. Med. 1991, 115: 455–456.

    Article  CAS  PubMed  Google Scholar 

  16. Matthews K.A., Kuller L.H., Wing R.R., Meilahn E.N., Plantinga P. Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am. J. Epidemiol. 1996, 143: 971–978.

    Article  CAS  PubMed  Google Scholar 

  17. Berman R., Epstein R., Lydick E. Risk factors associated with women’s compliance with estrogen replacement therapy. J. Women’s Health 1997, 6: 219–226.

    Article  CAS  Google Scholar 

  18. Brett K., Madans J. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am. J. Epidemiol. 1997, 145: 536–545.

    Article  CAS  PubMed  Google Scholar 

  19. Coronary Drug Project Research Group. Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project. N. Engl. J. Med. 1980, 303: 1038–1041.

    Article  Google Scholar 

  20. Fiebach N.H., Viscoli C.M., Horwitz R.I. Differences between women and men in survival after myocardial infarction. JAMA 1990, 263: 1092–1096.

    Article  CAS  PubMed  Google Scholar 

  21. Gallagher E.J., Viscoli C.M., Horwitz R.I. The relationship of treatment adherence to the risk of death after myocardial infarction in women. JAMA 1993, 270: 742–744.

    Article  CAS  PubMed  Google Scholar 

  22. Espeland M., Marcovina S., Miller V., Wood P., Wasilauskas C., Sherwin R., Schrott H., Bush T. Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. Circulation. 1998, 97: 979–986.

    Article  CAS  PubMed  Google Scholar 

  23. Mosca L., Jahnige K., Giacherio D., Christman G., Johnson T. Beneficial effect of hormone replacement therapy on lipoprotein(a) levels in postmenopausal women. Prev. Cardiol. 1999, 2: 51–58.

    CAS  Google Scholar 

  24. Guetta V., Cannon R.O. Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women. Circulation 1996, 93: 1928–1937.

    Article  CAS  PubMed  Google Scholar 

  25. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., Vittinghoft V. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998, 280: 605–613.

    Article  CAS  PubMed  Google Scholar 

  26. Nabulsi A., Folsom A., White A., Patsch W., Heiss G., Wu K., Szklo M. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators. N. Engl. J. Med. 1993, 328: 1069–1075.

    Article  CAS  PubMed  Google Scholar 

  27. Ridker P. Intrinsic fibrinolytic capacity and systemic inflammation: novel risk factors for arterial thrombotic disease. Haemostasis 1997, 27 (Suppl 1): 2–11.

    CAS  PubMed  Google Scholar 

  28. Paul S., Dean R., Tracy R., Cox D., Walsh B., Anderson P. Effects of raloxifene and hormone replacement therapy on homocysteine and C-reactive protein levels in postmenopausal women. Circulation 1998, 98 (Suppl): I7–I8 (abstract).

    Google Scholar 

  29. Karas R.H., Patterson B.L., Mendelsohn M.E. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994, 89: 1943–1950.

    Article  CAS  PubMed  Google Scholar 

  30. Chang W.C., Nakao J., Orimo H., Murota S.I. Stimulation of prostaglandin cyclooxygenase and prostacyclin synthetase activities by estradiol in rat aortic smooth muscle cells. Biochim. Biophys. Acta. 1980, 620: 472–480.

    Article  CAS  PubMed  Google Scholar 

  31. Lieberman E.H., Gerhard M.D., Uehara A., Walsh B.W., Selwyn A.P., Ganz P., Yeung A.C., Creager M.A. Estrogen improves endothelium-dependent, flowmediated vasodilation in postmenopausal women. Ann. Intern. Med. 1994, 121: 936–941.

    Article  CAS  PubMed  Google Scholar 

  32. Rosano G.M.C., Sarrel P.M., Poole-Wilson P.A., Collins P. Beneficial effect of oestrogen on exercise-induced myocardial ischemia in women with coronary artery disease. Lancet 1993, 342: 133–136.

    Article  CAS  PubMed  Google Scholar 

  33. Williams J. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990, 81: 1680–1687.

    Article  CAS  PubMed  Google Scholar 

  34. Reis S.E., Gloth S.T., Blumenthal R.S., Resar J.R., Zacur H.A., Gerstenblith G., et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994, 89: 52–60.

    Article  CAS  PubMed  Google Scholar 

  35. Blumenthal R., Brinker J., Resar J., Gloth S., Zacur H., Coombs V., Gerstenblith G., Reis S. Long-term estrogen therapy abolishes acute estrogen- induced coronary flow augmentation in postmenopausal women. Am. Heart J. 1997, 133: 323–328.

    Article  CAS  PubMed  Google Scholar 

  36. Fischer-Dzoga K., Wissler R., Vesselinovitch D. The effect of estradiol on the proliferation of rabbit aortic medial tissue cells induced by hyperlipemic serum. Exp. Mol. Pathol. 1983, 39: 355–363.

    Article  CAS  PubMed  Google Scholar 

  37. Vargas R., Wroblewska B., Rego A., Hatch J., Ramwell P.W. Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br. J. Pharmacol. 1993, 109: 612–617.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  38. Adams M.R., Kaplan J.R., Manuck S.B., Koritnik D.R., Parks J.S., Wolfe M.S., Clarkson T.B. Inhibition of coronary artery atherosclerosis by 17- beta estradiol in ovariectomized monkeys. Arteriosclerosis 1990, 10: 1051–1057.

    Article  CAS  PubMed  Google Scholar 

  39. CAST. Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N. Engl. J. Med. 1989, 321: 406–412.

    Google Scholar 

  40. Grady D., Gebretsadik T., Kerlikowske K., Ernster V., Petitti D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet. Gynecol. 1995, 85: 304–313.

    Article  CAS  PubMed  Google Scholar 

  41. Adams M.R., Register T.C., Golden D.L., Wagner J.D., Williams J.K. Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 1997, 17: 217–221.

    Article  CAS  PubMed  Google Scholar 

  42. Pirhonen J., Vuento M., Makinen J., Salmi T. Long-term effects of hormone replacement therapy on the uterus and on uterine circulation. Am. J. Obstet. Gynecol. 1993, 168: 620–630.

    Article  CAS  PubMed  Google Scholar 

  43. Sullivan J.M., Shala B.A., Miller L.A., Lerner J.L., McBrayer J.D. Progestin enhances vasoconstrictor responses in postmenopausal women receiving estrogen replacement therapy. Menopause 1995, 2: 193–199.

    Article  Google Scholar 

  44. Sarrel P.M. How progestins compromise the cardioprotective effects of estrogens. Menopause 1995, 2: 187–190.

    Article  Google Scholar 

  45. Coronary Drug Project Research Group. The Coronary Drug Project — initial findings leading to modifications of its research protocol. JAMA 1970, 214: 1303–1313. 46. Coronary Drug Project Research Group. The Coronary Drug Project — Findings leading to discontinuation of the 2.5-mg/day estrogen group. JAMA 1973, 226: 652–657.

    Article  Google Scholar 

  46. Hemminki E., McPherson K. Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials. BMJ 1997, 315: 149–153.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  47. The Women’s Health Initiative Study Group. Design of the Women’s Health Initiative clinical trial and observational study. Controlled Clin. Trials 1998, 19: 61–109.

    Article  Google Scholar 

  48. Delmas P., Bjarnason N., Mitlak B., Ravoux A., Shah A., Huster W., Draper M., Christiansen C. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N. Engl. J. Med. 1997, 337: 1641–1647.

    Article  CAS  PubMed  Google Scholar 

  49. Fisher B., Costantino J., Wickerham D., Redmond C., Kavanah M., Cronin W., Vogel V., Robidoux A., Dimitrov N., Atkins J. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. JNCI 1998, 90: 1371–1388.

    Article  CAS  PubMed  Google Scholar 

  50. Cummings S., Eckert S., Kreuger K., Grady D., Norton L., Nickelsen T., Bjarnason N., Morrow M., Lippman M., Black D., Glusman J., Costa A., Jordan V. Raloxifene treatment is associated with reduced risk of breast cancer in postmenopausal women with osteoporosis. JAMA 1999, 281 (in press).

    Google Scholar 

  51. Cattaneo M., Baglietto L., Zighetti M., Bettega D., Robertson C., Costa A., Mannucci P., Decenzi A. Tamoxifen reduces plasma homocysteine levels in healthy women. Br. J. Cancer 1998, 77: 2264–2266.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  52. Rahimian R., Laher I., Dube G., van Breemen C. Estrogen and selective estrogen receptor modulator LY117018 enhance release of nitric oxide in rat aorta. J. Pharmacol. Expr. Ther. 1997, 283: 116–122.

    CAS  Google Scholar 

  53. Loo S., Lesoon-Wood L., Cooney R. Effects of tamoxifen on nitric oxide synthesis and neoplastic transformation in C3H 10T1/2 fibroblasts. Cancer Lett. 1998, 122: 67–75.

    Article  CAS  PubMed  Google Scholar 

  54. Wiernicki T., Bean J., Dell C., Williams A., Wood D., Kauffman R., Singh J. Inhibition of vascular smooth muscle cell proliferation and arterial intimal thickening by a novel antiproliferative naphthopyran. J. Pharmacol. Expr. Ther. 1996, 278: 1452–1459.

    CAS  Google Scholar 

  55. Clarkson T., Anthony M., Jerome C. Lack of effect of raloxifene on coronary artery atherosclerosis of postmenopausal monkeys. J. Clin. Endocrinol. Metab. 1998, 83: 721–726.

    CAS  PubMed  Google Scholar 

  56. Early Breast Cancer Trialists’ Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992, 339: 71–85.

    Google Scholar 

  57. Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. JAMA 1996, 275: 370–375.

    Article  Google Scholar 

  58. Greendale G., Reboussin B., Hogan P., Barnabei V., Shumaker S., Johnson S., Barrett-Connor E. Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/ Progestin Interventions Trial. Obstet. Gynecol. 1998, 92: 982–988.

    Article  CAS  PubMed  Google Scholar 

  59. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997, 350: 1047–1059.

    Article  Google Scholar 

  60. Fisher B., Dignam J., Bryant J., DeCillis A., Wickerham D., Wolmark N., Costantino J., Redmond C., Fisher E., Bowman D. Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J. Natl. Cancer Inst. 1996, 88: 1529–1542.

    Article  CAS  PubMed  Google Scholar 

  61. Fisher B., Costantino J., Redmond C., Fisher E., Wickerham D., Cronin W. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J. Natl. Cancer Inst. 1994, 86: 527–537

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Emory University School of Medicine, Thomas K. Glenn Memorial Building, 69 Butler Street, SE, Atlanta, Georgia, 30303, USA

    Nanette K. Wenger

  2. Departments of Epidemiology and of Medicine, University of California, San Francisco, USA

    D. Grady

Authors
  1. Nanette K. Wenger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Grady
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wenger, N.K., Grady, D. Postmenopausal hormone therapy, SERMs, and coronary heart disease in women. J Endocrinol Invest 22, 616–624 (1999). https://doi.org/10.1007/BF03343619

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343619

Key-words

Search

Navigation